Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Chicago
Ossium Health, Inc.
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Instituto Nacional de Cancer, Brazil
Roswell Park Cancer Institute
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Fred Hutchinson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Kentucky
Northwestern University
Ann & Robert H Lurie Children's Hospital of Chicago